Liu Jing, Lu Ting-Ting, Han De-Xiong, Wang Chao, Chen Li-Fang, Wang Chen-Yao, Fang Jian-Qiao
Department of Acupuncture and Moxibustion, Zhejiang Chinese Medical University, Hangzhou 310000, China.
Zhejiang Chinese Medical University, Hangzhou 310053.
Zhongguo Zhen Jiu. 2019 Jul 12;39(7):721-5. doi: 10.13703/j.0255-2930.2019.07.011.
To compare the therapeutic effects on the relevant symtoms in the patients with dry eye syndrome treated with the acupoint thread-embedding therapy versus topical artificial tears eye drops.
A total of 88 patients with dry eye syndrome of deficiency lacrima production were randomized into an acupoint thread-embedding therapy group (thread-embedding group) and a control group with topical artificial tears eye drops (medication group), 44 cases in each one. In the thread-embedding group, 3 cases were dropped out. In the thread-embedding group, Ganshu (BL 18), Pishu (BL 20) and Shenshu (BL 23) etc. were selected and the acupoint thread-embedding therapy was operated once every 30 days, totally for two treatments. In the medication group, the topical artificial tears eye drops was used, 4 to 6 times a day, one drop each time, for 8 weeks totally. Separately, before treatment, after 4-week treatment and 8-week treatment as well as in 8 weeks and 12 weeks of the follow-up, the levels of lactoferrin in tears were determined and the scores of the relevant symptoms of ocular surface such as eye dryness, foreign body sensation in the eyes and eye fatigue were evaluated.
In the thread-embedding group, after 4-week and 8-week of treatment as well as in 8-week and 12-week follow-up, the scores of eye dryness, foreign body sensation, burning sensation of eye, phengophobia and eye fatigue were reduced significantly as compared with those before treatment (all <0.05). In the medication group, the relevant symptoms of ocular surface were reduced after 4-week and 8-week treatment as compared with those before treatment (all <0.05). In the follow-up, the scores of the relevant symptoms of ocular surface in the thread-embedding group were significantly lower than the medication group (all <0.05). Separately, after 4-week treatment and 8-week treatment as well as in 8 weeks and 12 weeks of the follow-up, the levels of lactoferrin in tears in the thread-embedding group were significantly increased as compared with those before treatment (all <0.05). The change was not obvious as compared with that before treatment in the medication group (>0.05). The levels of lactoferrin in tears at each time point after treatment in the thread-embedding group were higher than the medication group (<0.05).
The acupoint thread-embedding therapy effectively improves in the relevant symptoms of ocular surface, such as eye dryness, foreign body sensation, burning sensation of eye, phengophobia and eye fatigue, and increases the level of lactoferrin in tears in the patients with dry eye syndrome of deficiency aqueous production. In the follow-up, the therapeutic effects of the acupoint thread-embedding therapy are significantly better than artificial tears eye drops.
比较穴位埋线疗法与局部应用人工泪液滴眼液治疗干眼症患者相关症状的疗效。
将88例泪液分泌不足型干眼症患者随机分为穴位埋线治疗组(埋线组)和局部应用人工泪液滴眼液对照组(药物组),每组44例。埋线组有3例退出。埋线组选取肝俞(BL 18)、脾俞(BL 20)、肾俞(BL 23)等穴位,每30天进行1次穴位埋线治疗,共治疗2次。药物组局部应用人工泪液滴眼液,每天4至6次,每次1滴,共治疗8周。分别于治疗前、治疗4周后、8周后以及随访8周和12周时,测定泪液中乳铁蛋白水平,并评估眼干、眼异物感、眼疲劳等眼表相关症状的评分。
埋线组治疗4周、8周后以及随访8周、12周时,眼干、异物感、眼烧灼感、畏光、眼疲劳评分较治疗前均显著降低(均P<0.05)。药物组治疗4周、8周后眼表相关症状较治疗前降低(均P<0.05)。随访时,埋线组眼表相关症状评分显著低于药物组(均P<0.05)。分别于治疗4周、8周后以及随访8周、12周时,埋线组泪液中乳铁蛋白水平较治疗前显著升高(均P<0.05)。药物组与治疗前比较变化不明显(P>0.05)。埋线组治疗后各时间点泪液中乳铁蛋白水平均高于药物组(P<0.05)。
穴位埋线疗法能有效改善泪液分泌不足型干眼症患者眼干、异物感、眼烧灼感、畏光、眼疲劳等眼表相关症状,并提高泪液中乳铁蛋白水平。随访时,穴位埋线疗法的疗效显著优于人工泪液滴眼液。